Ranjani Rangan’s Post

This can be a great option especially during the requirements and development stages.

⚡ “Striking the right balance between friction and value is a defining factor of the neurotech startups that I consider seriously for investment" 👼 Angel investor Peter Zhegin (approx.vc, 7percent Ventures) spills all his investor-y secrets in the latest original publication from NeuroTechX's Content Laboratory. What did we learn? Turns out the only things standing between a neurotech start-up and make-or-break capital is: ⚖ A value proposition greater than user investment in the product 📈 A realistic path to scaling 🤖 An ability to leverage tech rather than be limited by it Who knew it was so simple?! Read on to find out that it actually isn't! Thanks to Lewis Bates, Yildiz Dilara Parry and Lars Olsen for your contributions to this article. Learn more about the Content Lab and get involved: https://lnkd.in/eg8ZGPJH 👩🎨 Check the comments for a DALL.E-generated artwork blooper. Has anyone cracked getting AIs to spell properly yet?! #neurotech #startup #scaleup #investing

Yes - 100% violently agree on everything Dr. James Somauroo articulates here - VC is more suited to areas where you can actually force scale in a consumer market. Public sector system proliferation CANNOT really be forced with capital IMHO, and as he says it just focuses on things that look like the biggest thing, but at the expense of so much in terms of value and improvement. There is pretty much zero proof that VC is a successful funding model for public sector healthtech. Period. On the system, I think mini versions of the DARPA model, and what Marianna Mazzucato advocates, lowering barriers as James says. The NHS isn't one thing - it's thousands and thousands of individual contexts. But right now the way that the NHS does this is also focused on the big stuff (probably in response to the market) and would need to root and branch change. I'm with you James.

Nucleate’s Global Virtual Activator is hosting its 2024 Demo Day on Friday, 31 May! RSVP: https://lu.ma/mojx7ns7 Teams from around the world will be pitching their novel biotech ventures. Along the Bio track, you will witness novel therapeutics and diagnostics advancing human health. And along the Eco track, innovations for sustainability will be featured. The Global Virtual Activator expands Nucleate's flagship program to teams from regions that don't yet have a robust Nucleate presence—advancing our mission to democratize access to biotech entrepreneurship education for tomorrow’s industry leaders at global scale. This year’s cohort is our most geographically and culturally diverse to date, with 28 finalists working in 14 teams across 27 cities, 12 countries, and 4 continents. In the past four months, we have connected finalist teams to 58 seasoned experts staffing the highest ranks of biotech VC, policy, and law. Our teams will work with 20+ more experts to refine their venture strategies in the coming two weeks, right up to Demo Day. We are incredibly proud of this year’s cohort and can’t wait for them to share their ventures! Read more about Activator: https://shorturl.at/APQR2 Meet this year’s 158 Activator ventures: https://shorturl.at/bivHX Shaye Carver Will Barr Daniel Lin Daniela Rodriguez Manrique Vivian Chu Regan Ellis Ashley Lin Julien Minniti Shawn Kang Md Imtiaz Khalil, Ph.D. Renee (Hui Xin) Ng Elena Del Pup Martin Holub Venkat Shashank Vege Cindy Lu Juan A. Garcia-Sanchez, Ph.D. Anurag Koyyada Jo Ann E. Michael Anderson Kevin Antonio Cahya Michael Retchin Heer Joisher Zach Cogan Julia Nanyi Zhao, PhD Yanan Wu Samantha Sison "Nick" Cheng-Yen Huang

MedTech Startup Podcast (or Vidcast?): Alex M. Forshey, Partner at Revival Healthcare Capital, and Giovanni Lauricella, Managing Partner of Lifeblood , sat down at Texas Medical Center Innovation (TMCi) in Houston, Texas to discuss "Build to Buy" and investment strategies in medical device companies as well as the role that family offices play in MedTech. Alex shares insightful information about various investment platforms, specifically the 'Build to Buy' concept in MedTech. He also offers a unique window into the workings of family offices and their importance in the investment ecosystem. Alex provides valuable advice for MedTech entrepreneurs, highlighting the need for diversity, active engagement and mindful listening in the boardroom. He shares his personal journey from investment banking to healthcare VC, stressing the contribution of his mentors and his drive to make a meaningful impact in healthcare. The conversation wraps up with a discussion on Houston’s growing potential as a MedTech hub. This episode is a must-listen for anyone interested in the financial dynamics and challenges of the MedTech industry. 00:05 Introduction to Family Offices and Wealth Management 00:54 Welcome to the MedTech Startup Podcast 01:34 Getting to Know Alex Forshey 02:31 Alex's Journey into the World of Family Offices 04:02 Transitioning to Investment Banking and Revival Healthcare Capital 05:35 Understanding Revival's Investment Strategy 20:28 The Role of Family Offices in Investment 29:44 The Future of MedTech in Texas 35:23 The Importance of Good Board Members 40:30 Alex's Personal Mentorship Experience 41:54 Conclusion and Final Thoughts Hope ya'll enjoy what Alex M. Forshey has to say, and take notes on the intriguing investment strategies that Revival Healthcare Capital deploys! With love for shaking MedTech insights loose from good humans and sharing them with the community, Mister MedTech P.S. Come on ya'll...like and subscribe to the MedTech Startup YouTube channel here: https://lnkd.in/e6Quni7z ...

(NEW POST) Considering the radical transformations in the sector, health tech startups can attract the right investors using appropriate strategies. This segment is undergoing shifts in how healthcare reaches patients, and the key triggers are technological advancements and the pandemic. Delivering health care using data or equipment and running diagnostics is easily done with AI-driven instruments and tools. Most importantly, the stress is entirely on sustainability and organizations need to not only comply with regulatory requirements. But also cater to customer demand. Providing care remotely and holistically that goes beyond physical well-being is also increasing in demand. For a founder, developing solutions to these challenges and building health tech startups can attract the right investors. #entrepreneurs #entrepreneurship #entrepreneur #business #success #venture #venturecapital #investment #invest #investors #tech #technology #innovation #leanstartup #leanstartups #inspiration #startup #startups https://lnkd.in/egZvkSxM

Exploring the Healthtech Startup Ecosystem: A Guide to Funding and Growth The healthcare technology sector is booming, offering unprecedented opportunities for entrepreneurs eager to make a difference. Here’s what you need to know: 👉Identify Your Niche: Consider areas like telehealth, wearable devices, AI diagnostics, or personalized medicine. 👉 Develop a Strong Value Proposition: Articulate how your solution addresses a gap or pain point in the healthcare system. A compelling value proposition that combines innovation with cost-effectiveness can attract the attention of both investors and customers. 👉 Understand Regulatory Requirements: Healthtech startups must navigate complex regulatory landscapes. 👉 Network with Industry Insiders: Relationships matter in the healthtech sector. Attend industry conferences, join relevant online communities, and connect with mentors who have experience in healthcare entrepreneurship. 👉 Secure the Right Type of Funding: Funding options vary widely, from venture capital and angel investors to government grants and crowdfunding. Each has its merits and considerations. For instance, VC funding might come with expertise and networks, while grants don't dilute ownership. 👉 Showcase Traction and Milestones: Investors want to see progress. Use early customer feedback, pilot programs, or clinical trial results to demonstrate market validation. Metrics on user engagement, cost savings, or improved health outcomes are powerful. 👉 Leverage Technology Partnerships: Collaborate with tech firms, research institutions, or other startups to enhance your offering. Partnerships can help you scale, improve your technology, and provide validation in the eyes of investors and customers. 👉 Prepare for Scaling Challenges: Growth in the healthtech sector requires careful planning. Consider how your supply chain, customer support, and backend systems will handle increased demand. Scalability is a critical factor for investors. 👉 Emphasize Impact: Beyond financial returns, many investors are interested in the social impact of their investments. Highlight how your solution can improve lives, reduce disparities, or make healthcare more accessible. 👉 Stay Informed About Industry Trends: The healthtech landscape is rapidly evolving. Keep abreast of technological advancements, policy changes, and emerging health challenges. Agility and the ability to pivot can be key assets. Remember, success in the healthtech sector demands not just a great idea, but a strategic approach to development, funding, and scaling. By understanding the ecosystem, aligning with the right partners, and focusing on impactful solutions, you can navigate the complexities of healthcare. #healthcare #entrepreneurship #future of #medicine #startup #healthtech

In today's business world, the distinction between startups that simply apply technology and those that lead technological and scientific breakthroughs is crucial. 🔬 Our latest article delves deep into the realm of Deep Tech, unraveling its profound impact on the business landscape. What sets apart these trailblazers from the tech-trend followers? And how are their groundbreaking innovations revolutionizing entire industries? ➡️Find out here:   https://lnkd.in/gkv3DiMU #FrissOncapital #PedroLopezSela #Podcast #Innovation #DeepTech #startups #Technology.

This week Mikal Ventures brings you a 4-week breakdown of the non-US capital market with an emphasis on the Mikal verticals. Over the 4-week period ending June 24, just over 1,160 new companies were added, with 102,850 companies included in the non-US Health Tech, Med Tech, Fin Tech, AI Tech, and Ed Tech verticals. The non-US AI Tech saw the greatest percentage growth in new companies for the period at 16%, vs. the vertical average of 11% for the period. The non-US Health Tech vertical led the group in transactions. The non-US Med Tech vertical lead in both SEC Filings and news articles. Mikal Ventures publishes these stats on a rolling 4-week basis to provide a perspective on how the verticals and new startups move through time. We hope you find them informative and thought-provoking. VC Investors are always adjusting their "Play Book" with a variety of options for investing. Mikal Ventures is one of those alternatives, offering curated solutions to real world problems. Reach out if you have questions on how we can be of assistance and bookmark https://mikalventures.com/ for additional insights and information.

This week Mikal Ventures brings you a 4-week breakdown of the non-US capital market with an emphasis on the Mikal verticals. Over the 4-week period ending June 24, just over 1,160 new companies were added, with 102,850 companies included in the non-US Health Tech, Med Tech, Fin Tech, AI Tech, and Ed Tech verticals. The non-US AI Tech saw the greatest percentage growth in new companies for the period at 16%, vs. the vertical average of 11% for the period. The non-US Health Tech vertical led the group in transactions. The non-US Med Tech vertical lead in both SEC Filings and news articles. Mikal Ventures publishes these stats on a rolling 4-week basis to provide a perspective on how the verticals and new startups move through time. We hope you find them informative and thought-provoking. VC Investors are always adjusting their "Play Book" with a variety of options for investing. Mikal Ventures is one of those alternatives, offering curated solutions to real world problems. Reach out if you have questions on how we can be of assistance and bookmark https://mikalventures.com/ for additional insights and information.